A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve
Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
Currently, no drugs have been developed for DOR. We developed the Chinese herbal compound
TJAOA101 and has validated its effects in animals. Here, we will perform a population-based,
multicenter study to confirm the safety and efficacy of TJAOA101 in therapy of DOR. We aim to
provide a solid evidence for TCM in therapy of DOR.